RESUMO
With regard to a case of acute fatty liver disease of pregnancy, concerning a primigravida patient, during a twin pregnancy, having survived to a severe form and with two-fetus death in utero. Extreme blood hypocoagulability induced cataclysmic bleeding and threatened the life of the patient who had survived only after the ligature of internal iliac arteries. Nevertheless, one year later, another normal pregnancy was uneventful.
Assuntos
Fígado Gorduroso/complicações , Complicações na Gravidez , Gravidez , Doença Aguda , Adulto , Feminino , Morte Fetal/etiologia , Humanos , Gêmeos , Hemorragia Uterina/etiologia , Hemorragia Uterina/cirurgiaRESUMO
Thoracic endometriosis is a rare disease, which presents in women at a mean age of 35 years, later than for pelvic endometriosis. There are no known predisposing factors for the condition and its pathogenesis is not yet clearly established. The symptoms always appear in connection with the periods of the person affected by the condition, occurring within 24-48 h after the start of menstruation. Catamenial pneumothorax is the most common clinical entity. It is associated with pelvic endometriosis in 30-50% of cases. Thoracoscopy, preferably performed during menstruation, allows full inspection of the diaphragm and the pleural cavity for defects in the diaphragm, endometrial nodules and bullae. The level of CA 125 is often elevated but this is not a reliable or specific marker. Medical treatment is aimed at blocking the action of estrogen on the endometrium and ectopic endometrial implants. GnRH analogues or danazol are the preferred treatments. Surgery to repair and strengthen the diaphragm and/or resect nodules or bullae also has a role, supplemented by pleurodesis to prevent further pneumothorax or effusions. The main risk is recurrence, and thus the current usual practice is to combine surgery, immediately followed by hormone therapy focusing on GnRH analogues.
Assuntos
Endometriose/diagnóstico , Doenças Torácicas/diagnóstico , Adulto , Biomarcadores/sangue , Antígeno Ca-125/sangue , Terapia Combinada , Danazol/uso terapêutico , Diagnóstico Diferencial , Endometriose/sangue , Endometriose/complicações , Endometriose/tratamento farmacológico , Endometriose/cirurgia , Moduladores de Receptor Estrogênico/uso terapêutico , Feminino , Hormônio Liberador de Gonadotropina/agonistas , Humanos , Leuprolida/uso terapêutico , Pessoa de Meia-Idade , Pneumotórax/etiologia , Enfisema Pulmonar/diagnóstico , Recidiva , Doenças Torácicas/sangue , Doenças Torácicas/tratamento farmacológico , Doenças Torácicas/cirurgia , Cirurgia Torácica Vídeoassistida , Toracoscopia , Deficiência de alfa 1-Antitripsina/diagnósticoRESUMO
Uterine rupture after myomectomy is rare but serious. It can occur before onset of labor and compromise vital maternofoetal outcome. We report the case of a uterine rupture at 25-week gestation in a 38-year-old primiparous woman after myomectomy and we will present a review of the literature concerning obstetric outcome after myomectomy.